Role of miR-301b-3p/5p in breast cancer: A study based on the cancer GenomeAtlas program (TCGA) and bioinformatics analysis

S Jane, 2020, Annual report to the nation on the status of cancer, part I: national cancer statistics, Cancer, 126, 2225, 10.1002/cncr.32802 Ferlay, 2021, Cancer statistics for the year 2020: an overview, Int. J. Cancer, 10.1002/ijc.33588 Yang, 2012, Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1, Gynecol. Oncol., 124, 325, 10.1016/j.ygyno.2011.10.013 Li, 2013, CpG island hypermethylation-associated silencing of microRNAs promotes human endometrial cancer, Cancer Cell Int., 13, 44, 10.1186/1475-2867-13-44 Chen, 2015, MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2, Mol. Carcinog., 54, 1292, 10.1002/mc.22204 Zhang, 2019, microRNA arm-imbalance in part from complementary targets mediated decay promotes gastric cancer progression, Nat. Commun., 10, 4397, 10.1038/s41467-019-12292-5 Guo, 2015, Evolutionary and expression analysis of miR-#-5p and miR-#-3p at the miRNAs/isomiRs levels, BioMed Res. Int., 2015, 10.1155/2015/168358 Yu, 2012, clusterProfiler: an R package for comparing biological themes among gene clusters, OMICS A J. Integr. Biol., 16, 284, 10.1089/omi.2011.0118 Liu, 2018, An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics, Cell, 173, 400, 10.1016/j.cell.2018.02.052 Agarwal, 2015, Predicting effective microRNA target sites in mammalian mRNAs, Elife, 4, 10.7554/eLife.05005 Kanehisa, 2021, KEGG mapping tools for uncovering hidden features in biological data, Protein Sci. : Publicat. Protein Soc. Jiao, 2012, DAVID-WS: a stateful web service to facilitate gene/protein list analysis, Bioinformatics, 28, 1805, 10.1093/bioinformatics/bts251 Bindea, 2013, Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer, Immunity, 39, 782, 10.1016/j.immuni.2013.10.003 Hanzelmann, 2013, GSVA: gene set variation analysis for microarray and RNA-seq data, BMC Bioinf., 14, 7, 10.1186/1471-2105-14-7 Tian, 2017, Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming, Nature, 544, 250, 10.1038/nature21724 Li, 2012, miRNA arm selection and isomiR distribution in gastric cancer, BMC Genom., 13, S13, 10.1186/1471-2164-13-S1-S13 Griffiths-Jones, 2011, MicroRNA evolution by arm switching, EMBO Rep., 12, 172, 10.1038/embor.2010.191 Tsai, 2016, Arm selection preference of MicroRNA-193a varies in breast cancer, Sci. Rep., 6, 10.1038/srep28176 Wagschal, 2015, Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis, Nat. Med., 21, 1290, 10.1038/nm.3980 Zhou, 2019, A positive feedback loop between cancer stem-like cells and tumor-associated neutrophils controls hepatocellular carcinoma progression, Hepatology, 70, 1214, 10.1002/hep.30630 Ramalho-Carvalho, 2017, Downregulation of miR-130b∼301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer, J. Hematol. Oncol., 10, 43, 10.1186/s13045-017-0415-1 Man, 2019, USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer, J. Exp. Clin. Cancer Res. : CR, 38, 259, 10.1186/s13046-019-1262-4 Wu, 2016, Hypoxia-induced microRNA-301b regulates apoptosis by targeting Bim in lung cancer, Cell Prolif., 49, 476, 10.1111/cpr.12264 Li, 2019, microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer, Stem Cell Res. Ther., 10, 144, 10.1186/s13287-019-1235-8 Peng, 2021, miR-301b and NR3C2 co-regulate cells malignant properties and have the potential to be independent prognostic factors in breast cancer, J. Biochem. Mol. Toxicol., 35, 10.1002/jbt.22650 Giussani, 2021, Circulating miRNAs as novel non-invasive biomarkers to aid the early diagnosis of suspicious breast lesions for which biopsy is recommended, Cancers, 13, 10.3390/cancers13164028 Lu, 2021, MiR-301b-3p promotes the occurrence and development of breast cancer cells via targeting HOXA5, Crit. Rev. Eukaryot. Gene Expr., 31, 35, 10.1615/CritRevEukaryotGeneExpr.2021038215 Fan, 2021, miR-301b-3p regulates breast cancer cell proliferation, migration, and invasion by targeting NR3C2, J. Oncol., 2021, 10.1155/2021/8810517 Song, 2018, MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD, BMB Rep., 51, 602, 10.5483/BMBRep.2018.51.11.168 Chang, 2015, Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing, Mol. Cancer, 14, 36, 10.1186/s12943-015-0301-9 Nakhjavani, 2022, Future of PD-1/PD-L1 axis modulation for the treatment of triple-negative breast cancer, Pharmacol. Res., 175, 10.1016/j.phrs.2021.106019 Nunez Abad, 2022, Programmed death-ligand 1 (PD-L1) as immunotherapy biomarker in breast cancer, Cancers, 14, 10.3390/cancers14020307 Yang, 2023, Immunotherapy targeting PD-1/PD-L1 in early-stage triple-negative breast cancer, J. Personalized Med., 13, 10.3390/jpm13030526